vimarsana.com

Latest Breaking News On - Nelly mugo - Page 1 : vimarsana.com

Single-Dose HPV Vaccine: What to Know | Bill & Melinda Gates Foundation

Anita Zaidi, the head of the Gates Foundation’s Gender Equality Division, explains how going down to one dose of the vaccine that prevents cervical cancer could save the lives of thousands of women each year.

Vaginal Insert Containing ART to Be Evaluated in Women for On-Demand HIV Prevention

On-demand HIV prevention method for women b

<p>A fast-dissolving vaginal insert that women would use at or around the time of sex as an &ldquo;on-demand&rdquo; HIV prevention method is being evaluated in a new early phase study being conducted by <a href="https://www.matrix4prevention.org/">MATRIX</a>, a United States Agency for International Development (USAID)-funded project focused on the early research and development of innovative HIV prevention products for women.&nbsp; The MATRIX study is only the second Phase 1 trial of the <a href="https://www.matrix4prevention.org/products/tafevg-fast-dissolving-vaginal-insert">fast-dissolving insert</a> used vaginally and the first to evaluate its use in African women. The insert, which contains the antiretroviral (ARV) drugs tenofovir alafenamide (TAF) and elvitegravir (EVG), is the only on-demand HIV prevention product for use by women currently being evaluated in clinical trials.</p>

New early phase study evaluates on-demand HIV prevention method for women

A fast-dissolving vaginal insert that women would use at or around the time of sex as an "on-demand" HIV prevention method is being evaluated in a new early phase study being conducted by MATRIX, a United States Agency for International Development (USAID)-funded project focused on the early research and development of innovative HIV prevention products for women.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.